Suppression by cyproheptadine of human growth hormone and cortisol secretion during sleep.
The effect of cyproheptadine on plasma growth hormone and cortisol levels was studied in seven male volunteers with polygraphic sleep monitoring. Sleep-related growth hormone release was completely inhibited in three of the seven normal subjects by the intravenous infusion of cyproheptadine (5 mg) which was started at the onset of sleep. In the other four, growth hormone release during sleep was significantly decreased or delayed by cyproheptadine when the drug infusion was started at 7:00 p.m., 1-2 h before the onset of sleep. The usual increase in plasma cortisol in the early morning was completely suppressed in all five subjects given cyproheptadine infusions from 4:00 to 7:00 a.m. The intravenous infusion of cyproheptadine increased slow wave sleep, although the time from sleep onset to the first occurrence of slow wave sleep was not affected. In contrast, rapid eye movement sleep was significantly decreased by cyproheptadine. These results suggest that cyproheptadine inhibits growth hormone and ACTH secretion during sleep in man, possibly by antagonizing serotoninergic mechanisms although other actions of the drug are not ruled out.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D003533:Cyproheptadine / Q000494:pharmacology*; D003864:Depression, Chemical; D004569:Electroencephalography; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000378:metabolism*; D008297:Male; D012890:Sleep / Q000502:physiology*; D012894:Sleep Stages / Q000187:drug effects
D003533:Cyproheptadine; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D006854:Hydrocortisone